Invenomic Capital Management’s Cardinal Health CAH Stock Holding History

Invenomic Capital Management’s Portfolio CAH Stock Details CAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-342,941	Closed	-$17.9M	–	152
2022 Q2	$17.9M	Buy	342,941 +142,459	+71%	+$8.1M	1.27%	18
2022 Q1	$11.4M	Buy	200,482 +10,893	+6%	+$583K	1.21%	21
2021 Q4	$9.76M	Buy	189,589 +67,590	+55%	+$3.32M	2.09%	8
2021 Q3	$6.03M	Buy	121,999 +33,920	+39%	+$1.84M	1.96%	12
2021 Q2	$5.03M	Buy	88,079 +29,239	+50%	+$1.71M	1.2%	15
2021 Q1	$3.57M	Buy	58,840 +37,720	+179%	+$2.08M	0.8%	23
2020 Q4	$1.13M	Sell	21,120 -24,241	-53%	-$1.26M	0.29%	69
2020 Q3	$2.13M	Buy	45,361 +17,544	+63%	+$900K	1.17%	28
2020 Q2	$1.45M	Buy	+27,817	New	+$1.43M	1.07%	35

Other funds holding CAH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Invenomic Capital Management's CAH Position: Q3 2022 in Review

Invenomic Capital Management sold out of Cardinal Health (CAH) in Q3 2022, closing a stake of 342,941 shares — an estimated $17.9M sold.

Invenomic Capital Management first reported a position in CAH in Q2 2020 and held it in 9 quarters. The position peaked at $17.9M in Q2 2022. 849 funds tracked by Wall St. Rank hold CAH as of Q3 2022.

Invenomic Capital Management reported no remaining Cardinal Health position as of Q3 2022 after selling out during the quarter.
Invenomic Capital Management sold 342,941 Cardinal Health shares in Q3 2022, an estimated $17.9M.
Invenomic Capital Management first reported a position in Cardinal Health in Q2 2020 and held it in 9 quarters.
Invenomic Capital Management's Cardinal Health position peaked at $17.9M in Q2 2022.
849 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2022.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.